Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
12.70
-0.71 (-5.29%)
At close: Mar 13, 2026, 4:00 PM EDT
12.53
-0.17 (-1.34%)
After-hours: Mar 13, 2026, 5:51 PM EDT
Enanta Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts that cover Enanta Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $20.4, which forecasts a 60.63% increase in the stock price over the next year. The lowest target is $12 and the highest is $28.
Price Target: $20.4 (+60.63%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 10, 2026.
Analyst Ratings
The average analyst rating for Enanta Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 4 | 4 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +57.48% | Feb 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +57.48% | Jan 9, 2026 |
| JP Morgan | JP Morgan | Buy Initiates $17 | Buy | Initiates | $17 | +33.86% | Nov 14, 2025 |
| WestPark Capital | WestPark Capital | Strong Buy Maintains $24 → $28 | Strong Buy | Maintains | $24 → $28 | +120.47% | Sep 30, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $20 → $12 | Buy | Maintains | $20 → $12 | -5.51% | Sep 15, 2025 |
Financial Forecast
Revenue This Year
69.19M
from 65.32M
Increased by 5.91%
Revenue Next Year
65.97M
from 69.19M
Decreased by -4.65%
EPS This Year
-2.42
from -3.84
EPS Next Year
-2.13
from -2.42
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 78.1M | 79.7M | |||
| Avg | 69.2M | 66.0M | |||
| Low | 59.3M | 52.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 19.6% | 15.2% | |||
| Avg | 5.9% | -4.6% | |||
| Low | -9.1% | -24.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.76 | -1.59 | |||
| Avg | -2.42 | -2.13 | |||
| Low | -3.09 | -2.71 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.